EUVIMEDOpdag EUVIMED
Open access · CC BY-NC 4.0

Structural studies of intrinsically disordered MLL ‐fusion protein AF9 in complex with peptidomimetic inhibitors

Yuting Yang iD, Ejaz Ahmad iD, Vidhya Premkumar, Alicen Liu, S M Ashikur Rahman iD, Zaneta Nikolovska-Coleska iD

Protein Science · 2024

DOI: 10.1002/pro.5019 ↗

At a glance

Journal article in Protein Science, 2024. Written by Yuting Yang and 5 co-authors. Institution: Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, USA. Major MEDLINE topics: Myeloid-Lymphoid Leukemia Protein, Peptidomimetics. Cited 7 times so far (Crossref); 65 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Circle Pharma, U.S. Department of Energy (DOE) Office of Science User Facility, Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

AF9 (MLLT3) and its paralog ENL(MLLT1) are members of the YEATS family of proteins with important role in transcriptional and epigenetic regulatory complexes. These proteins are two common MLL fusion partners in MLL ‐rearranged leukemias. The oncofusion proteins MLL‐AF9/ENL recruit multiple binding partners, including the histone methyltransferase DOT1L, leading to aberrant transcriptional activation and enhancing the expression of a characteristic set of genes that drive leukemogenesis. The interaction between AF9 and DOT1L is mediated by an intrinsically disordered C‐terminal ANC1 homology domain (AHD) in AF9, which undergoes folding upon binding of DOT1L and other partner proteins. We have recently reported peptidomimetics that disrupt the recruitment of DOT1L by AF9 and ENL, providing a proof‐of‐concept for targeting AHD and assessing its druggability. Intrinsically disordered proteins, such as AF9 AHD, are difficult to study and characterize experimentally on a structural level. In this study, we present a successful protein engineering strategy to facilitate structural investigation of the intrinsically disordered AF9 AHD domain in complex with peptidomimetic inhibitors by using maltose binding protein (MBP) as a crystallization chaperone connected with linkers of varying flexibility and length. The strategic incorporation of disulfide bonds provided diffraction‐quality crystals of the two disulfide‐bridged MBP–AF9 AHD fusion proteins in complex with the peptidomimetics. These successfully determined first series of 2.1–2.6 Å crystal complex structures provide high‐resolution insights into the interactions between AHD and its inhibitors, shedding light on the role of AHD in recruiting various binding partner proteins. We show that the overall complex structures closely resemble the reported NMR structure of AF9 AHD/DOT1L with notable difference in the conformation of the β‐hairpin region, stabilized through conserved hydrogen bonds network. These first series of AF9 AHD/peptidomimetics complex structures are providing insights of the protein–inhibitor interactions and will facilitate further development of novel inhibitors targeting the AF9/ENL AHD domain.

Subjects

MeSH terms (MEDLINE)

Myeloid-Lymphoid Leukemia ProteinPeptidomimeticsHumansCrystallography, X-RayHistone-Lysine N-MethyltransferaseIntrinsically Disordered ProteinsModels, MolecularOncogene Proteins, FusionProtein Domains

Author keywords

AF9DOT1LMBP fusionX‐ray crystallographydisulfide bridgeintrinsically disordered proteinspeptidomimetics

Substances

Histone-Lysine N-MethyltransferaseIntrinsically Disordered ProteinsMyeloid-Lymphoid Leukemia ProteinOncogene Proteins, FusionPeptidomimeticsMLL-AF9 fusion protein, humanDOT1L protein, human

Authors and institutions

  • Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
  • Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan, USA.

ORCID profiles: Yuting Yang, Ejaz Ahmad, S M Ashikur Rahman, Zaneta Nikolovska-Coleska

Funding

  • Circle Pharma
  • U.S. Department of Energy (DOE) Office of Science User Facility
  • Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor

Cite

APA

Yang, Y., Ahmad, E., Premkumar, V., Liu, A., Ashikur Rahman, S. M., & Nikolovska-Coleska, Z. (2024). Structural studies of intrinsically disordered MLL ‐fusion protein AF9 in complex with peptidomimetic inhibitors. Protein Science. https://doi.org/10.1002/pro.5019

Vancouver

Yang Y, Ahmad E, Premkumar V, Liu A, Ashikur Rahman SM, Nikolovska-Coleska Z. Structural studies of intrinsically disordered MLL ‐fusion protein AF9 in complex with peptidomimetic inhibitors. Protein Science. 2024. doi:10.1002/pro.5019

BibTeX
@article{Yang2024,
  author = {Yang, Yuting and Ahmad, Ejaz and Premkumar, Vidhya and Liu, Alicen and Ashikur Rahman, S M and Nikolovska-Coleska, Zaneta},
  title = {Structural studies of intrinsically disordered MLL ‐fusion protein AF9 in complex with peptidomimetic inhibitors},
  journal = {Protein Science},
  year = {2024},
  doi = {10.1002/pro.5019}
}
Start for free →